USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
DYNAMIS THERAPEUTICS, INC.
Address:
261 OLD YORK RD, SUITE 427
JENKINTOWN, PA 19046
Phone:
N/A
URL:
N/A
EIN:
123290934
DUNS:
122541894
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $257,579.00 1

Award List:

Discovery of FN3K Inhibitors to Treat Diabetic Complications

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$257,579.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The glucose metabolite 3-deoxyglucosone (3DG) is a highly reactive, dicarbonyl, proinflammatory molecule that induces oxidative stress and is a precursor to the formation of advanced glycation end products (AGEs), which are believed to be important in mechanisms… More